BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25998576)

  • 1. Organ donor specimens: What can they tell us about type 1 diabetes?
    Campbell-Thompson M
    Pediatr Diabetes; 2015 Aug; 16(5):320-30. PubMed ID: 25998576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insight on human type 1 diabetes biology: nPOD and nPOD-transplantation.
    Pugliese A; Vendrame F; Reijonen H; Atkinson MA; Campbell-Thompson M; Burke GW
    Curr Diab Rep; 2014 Oct; 14(10):530. PubMed ID: 25142715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes.
    Campbell-Thompson M; Wasserfall C; Kaddis J; Albanese-O'Neill A; Staeva T; Nierras C; Moraski J; Rowe P; Gianani R; Eisenbarth G; Crawford J; Schatz D; Pugliese A; Atkinson M
    Diabetes Metab Res Rev; 2012 Oct; 28(7):608-17. PubMed ID: 22585677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan deposition in islets may precede and direct the location of islet immune-cell infiltrates.
    Bogdani M; Speake C; Dufort MJ; Johnson PY; Larmore MJ; Day AJ; Wight TN; Lernmark Å; Greenbaum CJ
    Diabetologia; 2020 Mar; 63(3):549-560. PubMed ID: 31907557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulitis in the pancreas of non-diabetic organ donors under age 25 years with multiple circulating autoantibodies against islet cell antigens.
    Smeets S; De Paep DL; Stangé G; Verhaeghen K; Van der Auwera B; Keymeulen B; Weets I; Ling Z; In't Veld P; Gorus F
    Virchows Arch; 2021 Aug; 479(2):295-304. PubMed ID: 33594586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage.
    Nigi L; Maccora C; Dotta F; Sebastiani G
    Diabetes Metab Res Rev; 2020 May; 36(4):e3264. PubMed ID: 31850667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreas Pathology During the Natural History of Type 1 Diabetes.
    Rodriguez-Calvo T; Richardson SJ; Pugliese A
    Curr Diab Rep; 2018 Oct; 18(11):124. PubMed ID: 30293191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance Use Affects Type 1 Diabetes Pancreas Pathology: Implications for Future Studies.
    Bruggeman BS; Campbell-Thompson M; Filipp SL; Gurka MJ; Atkinson MA; Schatz DA; Jacobsen LM
    Front Endocrinol (Lausanne); 2021; 12():778912. PubMed ID: 34912300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A run on the biobank: what have we learned about type 1 diabetes from the nPOD tissue repository?
    Kaddis JS; Pugliese A; Atkinson MA
    Curr Opin Endocrinol Diabetes Obes; 2015 Aug; 22(4):290-5. PubMed ID: 26087339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings.
    Pugliese A; Yang M; Kusmarteva I; Heiple T; Vendrame F; Wasserfall C; Rowe P; Moraski JM; Ball S; Jebson L; Schatz DA; Gianani R; Burke GW; Nierras C; Staeva T; Kaddis JS; Campbell-Thompson M; Atkinson MA
    Pediatr Diabetes; 2014 Feb; 15(1):1-9. PubMed ID: 24325575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Hormone-Negative Endocrine Cells in the Pancreas in Type 1 Diabetes.
    Md Moin AS; Dhawan S; Shieh C; Butler PC; Cory M; Butler AE
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3487-96. PubMed ID: 27300574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes.
    Campbell-Thompson M; Fu A; Kaddis JS; Wasserfall C; Schatz DA; Pugliese A; Atkinson MA
    Diabetes; 2016 Mar; 65(3):719-31. PubMed ID: 26581594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreas tissue slices from organ donors enable in situ analysis of type 1 diabetes pathogenesis.
    Panzer JK; Hiller H; Cohrs CM; Almaça J; Enos SJ; Beery M; Cechin S; Drotar DM; Weitz JR; Santini J; Huber MK; Muhammad Fahd Qadir M; Pastori RL; Domínguez-Bendala J; Phelps EA; Atkinson MA; Pugliese A; Caicedo A; Kusmartseva I; Speier S
    JCI Insight; 2020 Apr; 5(8):. PubMed ID: 32324170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes.
    Rajendran S; Quesada-Masachs E; Zilberman S; Graef M; Kiosses WB; Chu T; Benkahla MA; Lee JM; von Herrath M
    J Autoimmun; 2021 Sep; 123():102708. PubMed ID: 34358764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression pattern of 12-lipoxygenase in human islets with type 1 diabetes and type 2 diabetes.
    Grzesik WJ; Nadler JL; Machida Y; Nadler JL; Imai Y; Morris MA
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E387-95. PubMed ID: 25532042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of IL-1β immunoreactive cells in pancreatic biopsies from living volunteers with new-onset type 1 diabetes: comparison with donors without diabetes and with longer duration of disease.
    Reddy S; Krogvold L; Martin C; Holland R; Choi J; Woo H; Wu F; Dahl-Jørgensen K
    Diabetologia; 2018 Jun; 61(6):1362-1373. PubMed ID: 29589071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the etiology and mechanisms of type 1 diabetes.
    Pugliese A
    Discov Med; 2014 Sep; 18(98):141-50. PubMed ID: 25227755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes.
    Quesada-Masachs E; Zilberman S; Rajendran S; Chu T; McArdle S; Kiosses WB; Lee JM; Yesildag B; Benkahla MA; Pawlowska A; Graef M; Pfeiffer S; Mikulski Z; von Herrath M
    Diabetologia; 2022 Feb; 65(2):387-401. PubMed ID: 34932134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes.
    Subauste A; Gianani R; Chang AM; Plunkett C; Pietropaolo SL; Zhang YJ; Barinas-Mitchell E; Kuller LH; Galecki A; Halter JB; Pietropaolo M
    PLoS One; 2014; 9(9):e106537. PubMed ID: 25226365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
    Christen U; Kimmel R
    Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.